Recombinant Human Platelet-Derived Growth Factor-BB and Beta-Tricalcium Phosphate (rhPDGF-BB/β-TCP): An Alternative to Autogenous Bone Graft

2013153 citationsJournal Article

Authors

Christopher W. DiGiovanni · Brown University

Sheldon S. Lin · University Hospital, Newark

Judith F. Baumhauer · University of Rochester

Timothy R. Daniels · St. Michael's Hospital

Alastair Younger · St. Paul's Hospital

Mark Glazebrook · Dartmouth General Hospital

John G. Anderson

Abstract

In patients requiring hindfoot or ankle arthrodesis, treatment with rhPDGF-BB/β-TCP resulted in comparable fusion rates, less pain, and fewer side effects as compared with treatment with autograft.

Topics & Keywords

Periodontal Regeneration and Treatments Bone Tissue Engineering Materials Osteoarthritis Treatment and Mechanisms

Publication Details

Published in: Journal of Bone and Joint Surgery

Volume 95, Issue 13, pp. 1184-1192

DOI: 10.2106/jbjs.k.01422

Field-Weighted Citation Impact: 8.84

Command Palette

Recombinant Human Platelet-Derived Growth Factor-BB and Beta-Tricalcium Phosphate (rhPDGF-BB/β-TCP): An Alternative to Autogenous Bone Graft

Authors

Abstract

Topics & Keywords

Publication Details